<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Sammaan Capital Limited

NSE: SAMMAANCAP · Lot size: 4300

Sammaan Capital Limited Open Interest & PCR Analysis

148.75Updated 21 Apr 2026, 01:26 pm IST
PCR
1.08
Neutral
Max Pain
150
Spot below by ₹1
Total CE OI
17.50M
Call writers
Total PE OI
18.89M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-18

Frequently Asked Questions

What is Sammaan Capital Limited PCR (Put-Call Ratio) today?
Sammaan Capital Limited's current PCR is 1.08. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Sammaan Capital Limited's PCR of 1.08 indicates neutral sentiment.
What is Sammaan Capital Limited OI buildup type today?
Sammaan Capital Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Sammaan Capital Limited?
Sammaan Capital Limited has total CE (call) OI of 17496700 contracts and total PE (put) OI of 18894200 contracts for the nearest expiry. The PCR is 1.08.
How is open interest analysis useful for Sammaan Capital Limited trading?
OI analysis for Sammaan Capital Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Sammaan Capital Limited?
Sammaan Capital Limited's max pain is ₹150 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.